Verapamil hcl and Mesenteric vein thrombosis - a phase IV clinical study of FDA data


Mesenteric vein thrombosis is reported only by a few people who take Verapamil Hcl.

The phase IV clinical study analyzes which people take Verapamil hcl and have Mesenteric vein thrombosis. It is created by eHealthMe based on reports of 4,737 people who have side effects while taking Verapamil hcl from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 15, 2022

4,737 people reported to have side effects when taking Verapamil hcl.
Among them, 3 people (0.06%) have Mesenteric vein thrombosis.

What is Verapamil hcl?

Verapamil hcl has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 5,308 Verapamil hcl users for its effectiveness, alternative drugs and more.

What is Mesenteric vein thrombosis?

Mesenteric vein thrombosis (blood clot in mesenteric vein) is found to be associated with 469 drugs and 266 conditions by eHealthMe.

Number of Verapamil hcl and Mesenteric vein thrombosis reports submitted per year:

Could Verapamil hcl cause Mesenteric vein thrombosis?

Gender of people who have Mesenteric vein thrombosis when taking Verapamil hcl *:

  • female: 0.0 %
  • male: 100 %

Age of people who have Mesenteric vein thrombosis when taking Verapamil hcl *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Verapamil hcl *:

  1. Prednisolone: 3 people, 100.00%
  2. Famotidine: 3 people, 100.00%
  3. Aspirin: 3 people, 100.00%
  4. Ribavirin: 2 people, 66.67%
  5. Rebetol: 1 person, 33.33%
  6. Protonix: 1 person, 33.33%
  7. Nexium: 1 person, 33.33%
  8. Dexilant: 1 person, 33.33%

Common side effects people have besides Mesenteric vein thrombosis *:

  1. Acidosis (build-up of carbon dioxide in the blood): 3 people, 100.00%
  2. Renal Impairment (severely reduced kidney function): 2 people, 66.67%
  3. Malaise (a feeling of general discomfort or uneasiness): 2 people, 66.67%
  4. Hepatic Function Abnormal: 2 people, 66.67%
  5. Ileal Perforation: 1 person, 33.33%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 33.33%
  7. Bone Disorder: 1 person, 33.33%
  8. Carpal Tunnel Syndrome (nerve compression at wrist results numbness weakness, pain , swelling): 1 person, 33.33%
  9. Cataract (clouding of the lens inside the eye): 1 person, 33.33%
  10. Compression Fracture (fracture due to pressure caused by injury): 1 person, 33.33%

Common conditions people have *:

  1. Hepatitis C: 3 people, 100.00%
  2. Urticaria (rash of round, red welts on the skin that itch intensely): 1 person, 33.33%
  3. Gastric Ulcer (stomach ulcer): 1 person, 33.33%
  4. Gastric Disorder (disease of stomach): 1 person, 33.33%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take Verapamil hcl and have Mesenteric vein thrombosis?

Check whether Mesenteric vein thrombosis is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Mesenteric vein thrombosis and when was it recovered:

Expand to all the drugs that have ingredients of verapamil hydrochloride:

Alternative drugs to, pros and cons of Verapamil hcl:

Common Verapamil hcl side effects:

Browse all side effects of Verapamil hcl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Mesenteric vein thrombosis treatments and more:

COVID vaccines that are related to Mesenteric vein thrombosis:

All the drugs that are associated with Mesenteric vein thrombosis:

Common conditions associated with Mesenteric vein thrombosis:

All the conditions that are associated with Mesenteric vein thrombosis:

How the study uses the data?

The study uses data from the FDA. It is based on verapamil hydrochloride (the active ingredients of Verapamil hcl) and Verapamil hcl (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: